Abstract: An electrochemical device including: (a) a semiconductor layer, wherein the semiconductor is silicon or silicon carbide, and where the layer has a thickness from 1 to 1000 ?m; (b) a TiO2 layer on the semiconductor layer, where the layer may include an alkaline earth oxide MO up to an amount where the layer is MtiO3, and where the layer has a thickness from 5 nm to 1 mm; (c) a grid of inert metal on the TiO2 layer, arranged so as to be able to apply a electric field across the TiO2 layer; and (d) an ohmic contact on the semiconductor layer.

Abstract: In a method and apparatus for establishing the position of one or more constituent elements of a phantom in an image quality test for a medical imaging apparatus, an image of the phantom is obtained, and a landmark pixel or region of the image determined. Values of a given variable at pixels or regions at a predetermined distance from the landmark pixel or region are determined. The landmark pixel or region and the values of the variable are then used to establish the position of one or more of the constituent elements of the phantom.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

Abstract: In a method and apparatus for identifying regions of interest in medical images of a subject, in particular images captured by a medical imaging apparatus, such as a PET scanner, a list of voxels of the image is obtained, and sorted according to a first variable. A user-selection of an initial voxel in the image is then registered, and at least one voxel or group of voxels from the sorted list is selected as a region of interest, according to a property of the at least one voxel or group in relation to the user-selected initial voxel. The image may be pre-processed to generate the sorted list of voxels, following which the user selection of the initial voxel is registered.

Abstract: A self-configuring verifier for performing standardized evaluation and verification of the print quality of a data carrying graphical symbol is structured with a plurality of illumination sources and at least one imaging device. The verifier is capable of automatically determining the symbology of the graphical symbol to be evaluated, and establish a pre-defined illumination pattern and possibly other settings, as required, to satisfy pre-defined evaluation standards. Once the illumination pattern is established and setup is complete, the verifier may fully evaluate and report on the quality of at least one data carrying graphical symbol imaged by the imaging device of the verifier. This abstract is provided to comply with rules requiring an abstract, and is submitted with the intention that it will not be used to interpret or limit the scope and meaning of the claims.

Abstract: A method of measuring an anode current in an electron-multiplier device having an anode, a cathode, dynodes and a voltage divider network for applying voltages to the dynodes, which method includes applying an HV positive voltage to the anode and intermediate voltages to the dynodes, the cathode being at or near circuit ground potential, conducting dynode currents through or in parallel to the voltage divider to a point substantially at cathode potential, and deriving from those currents a current representative of the anode current.

Abstract: Methods and systems of measuring progressive multilateral dysfunction of a system are provided. Methods of measuring progressive multilateral dysfunction of a system include, obtaining a plurality of different health measures for the system, defining a multidimensional space with one dimension corresponding to each health measures and defining a point in the multidimensional space representing the values of the health measures. Further the method includes, comparing the position of the defined point to a predefined trajectory through said multidimensional space representing progressive multilateral dysfunction of the system where the measure of the progressive multilateral dysfunction of the system is calculated from the position of the point relative to the predefined trajectory.

Abstract: The present invention relates to direct and reformate methanol fuel cells containing an anode comprising semiconductor layers. A semiconductor layer, preferably silicon or silicon carbide, is overlaid with a TiO2 layer. An open metal over-layer, preferably platinum optionally applied over a layer of inert metal such as gold, is deposited on the TiO2 layer, optionally in the form of a grid. It has been found that the active OH species generated in the presence and absence of light irradiation at the TiO2 surface in this device eliminates the need for ruthenium to be present. Furthermore, studies have unexpectedly shown that an electric field applied via an electrode on the surface of the TiO2 appears not to be required for the benefits to occur. This invention is thought to be particularly applicable to micro fuel cells.

Abstract: In a patient scanner and method, a scan image is registered with a reference image and superimposed. In an iterative process the images are normalized and the transparency varied to assist in the identification of abnormalities.

Abstract: The present invention relates to new tetralin compounds, the methods of preparing said tetralin compounds, the method of using said tetralin compounds as local anesthetics and dermal anesthetics, said compounds having particularly valuable properties as dermal and topical anesthetics in mammals, including man, as well as compositions containing said compounds.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

Abstract: Disclosed are protein biomarkers and their use in diagnosing head and neck squamous cell carcinoma (HNSCC) or to make a negative diagnosis in patients. Also disclosed are kits for the diagnosis of HNSCC that detect the protein biomarkers of the invention, as well as methods using a plurality of classifiers to make a probable diagnosis of HNSCC. In certain aspects of the invention, the methods include use of a decision tree analysis. Various computer readable media and their use according to the invention are also disclosed.

Abstract: A system and method are provided for using machine-readable technology to uniquely identify garments and to associate the garments with particular users, wherein the machine-readable technology is designed to withstand the various environments that are imposed upon a garment during its lifetime. The machine-readable technology includes identification tracking markers such as bar codes, magnetic tags, and other identification tracking markers that withstand laundering, mending, sterilizing and other processing.

Abstract: Protein biomarkers that may advantageously be utilized in aiding in, or making, a diagnosis of HTLV-I-associated myelopathy (HAM), adult T-cell leukemia (ATL) or a negative diagnosis are described. Accordingly, in one aspect of the invention, methods for aiding in, or otherwise making, a diagnosis of ATL, HAM or a negative diagnosis are provided. Methods of detecting the protein biomarkers, kits that may be utilized to detect the biomarkers, as well as isolated protein biomarkers are also provided.

Abstract: In a xerographic printing apparatus, a scorotron places a uniform charge on a photoreceptor for forming electrostatic latent images. Three conductive pin arrays are disposed in a housing defined by sidewalls and a screen adjacent the photoreceptor. There can be provided insulative walls between adjacent pin arrays. The screen and a surface of the housing can be curved to correspond to a curvature of the photoreceptor.

Abstract: This invention provides organic biomolecule markers (e.g., proteins) useful for differentiating prostate cancer, prostate intraepithelial neoplasia or benign prostate hyperplasia, from a negative diagnosis (i.e. normal and benign prostate epithelial cells).

Abstract: Protein biomarkers that may advantageously be utilized in diagnosing prostate cancer, benign prostate hyperplasia or to make a negative diagnosis are described. Accordingly, in one aspect of the invention, methods for aiding in, or otherwise making, a diagnosis of prostate cancer or benign prostate hyperplasia are provided. In one form of the invention, a method includes detecting various protein biomarkers of defined molecular weight and correlating the detection to a diagnosis of prostate cancer, benign prostate hyperplasia or to a negative diagnosis. In yet another aspect of the invention, kits are provided that may be utilized to detect the biomarkers described herein. In a further of the invention, methods of using a plurality of classifiers to make a probable diagnosis of prostate cancer of benign prostate hyperplasia are provided. In certain forms of the invention, the methods include use of a boosted decision tree analysis. Various computer readable media are also provided.

Abstract: Various embodiments of the present invention comprise endoscopes for viewing inside a cavity of a body such as a vessel like a vein or artery. These endoscopes may include at least one solid state emitter such as a light emitting diode (LED) that is inserted into the body cavity to provide illumination therein. Certain embodiments of the invention comprise disposable endoscopes that can be fabricated relatively inexpensively such that discarding these endoscopses after a single use is cost-effective. The endoscope may comprise a lens holder on a distal end of the endoscope for collection of light reflected from surfaces within the body in which the endoscope is inserted. This lens holder may have an inner cavity through which light passes along an optical path. Reflective surfaces on sidewalls of the inner cavity may direct light along this optical path. The endoscope may further comprise an elongated support structure for supporting a plurality of lenses disposed along the optical path.

Abstract: A system and method are provided for using machine-readable technology to uniquely identify garments and to associate the garments with particular users, wherein the machine-readable technology is designed to withstand the various environments that are imposed upon a garment during its lifetime. The machine-readable technology includes identification tracking markers such as bar codes, magnetic tags, and other identification tracking markers that withstand laundering, mending, sterilizing and other processing.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.